This picture shows the tablets of Ivermectin drugs in Tehatta, West Benga, India on 19 May on 2021. Some Indian state governments have plans to dose their populations with the anti-parasitic drug ivermectin to protect against severe COVID-19 infections as their hospitals are overrun with patients in critical condition. But, the World Health Organization (WHO) has warned against the use of this medicine in treating COVID-19 patients. (Photo by Soumyabrata Roy/NurPhoto via Getty Images)
The following assets contain unreleased and/or restricted content.
Images marked as Easy-access downloads are not included in your Premium Access or subscription package with Getty Images, and you will be billed for any images that you use.
Easy-access downloads let you quickly download hi-res, non-watermarked images. Unless you have a written agreement with Getty Images stating otherwise, Easy-access downloads are for comp purposes and are not licensed for use in a final project.
Your Easy-access (EZA) account allows those in your organization to download content for the following uses:
It overrides the standard online composite license for still images and video on the Getty Images website. The EZA account is not a license. In order to finalize your project with the material you downloaded from your EZA account, you need to secure a license. Without a license, no further use can be made, such as:
focus group presentations
final materials distributed inside your organization
any materials distributed outside your organization
any materials distributed to the public (such as advertising, marketing)
Because collections are continually updated, Getty Images cannot guarantee that any particular item will be available until time of licensing. Please carefully review any restrictions accompanying the Licensed Material on the Getty Images website, and contact your Getty Images representative if you have a question about them. Your EZA account will remain in place for a year. Your Getty Images representative will discuss a renewal with you.
By clicking the Download button, you accept the responsibility for using unreleased content (including obtaining any clearances required for your use) and agree to abide by any restrictions.